Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer
Open Access
- 26 November 2025
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 125 (1) , 257-265
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK (A28724)
- Cancer Research UK (RRCOER-Jun24/100006)
- Cancer Research UK (C33589/A28284)
- Royal Marsden NHS Foundation Trust
- National Institute for Health and Care Research
- Institute of Cancer Research
- Elekta
This publication has 36 references indexed in Scilit:
- Clinical Impact of Contouring Variability for Prostate Cancer Tumor BoostInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2024
- Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2023
- Magnetic Resonance Imaging–Guided vs Computed Tomography–Guided Stereotactic Body Radiotherapy for Prostate CancerJAMA Oncology, 2023
- A margin recipe for the management of intra-fraction target motion in radiotherapyPhysics and Imaging in Radiation Oncology, 2022
- On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapyPhysics and Imaging in Radiation Oncology, 2021
- Histopathological Features of MRI‐Invisible Regions of Prostate Cancer LesionsJournal of Magnetic Resonance Imaging, 2019
- Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective StudiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate CancerJAMA Oncology, 2018
- Gross tumor volume and clinical target volume in prostate cancer: How do satellites relate to the index lesionRadiotherapy and Oncology, 2015
- Sample size tables for exact single‐stage phase II designsStatistics in Medicine, 2001